| scholarly article | Q13442814 |
| P50 | author | Carl R Lupica | Q64779171 |
| P2093 | author name string | Arthur C Riegel | |
| P2860 | cites work | Two types of neurone in the rat ventral tegmental area and their synaptic inputs | Q24531393 |
| Brain reward circuitry: insights from unsensed incentives | Q28207855 | ||
| The significance of action potential bursting in the brain reward circuit | Q28217710 | ||
| Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists | Q28370656 | ||
| Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme | Q28372132 | ||
| Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system | Q28579812 | ||
| Predictive reward signal of dopamine neurons | Q29615397 | ||
| Getting formal with dopamine and reward | Q29618725 | ||
| Pharmacology and functions of metabotropic glutamate receptors | Q29619150 | ||
| Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method | Q68996730 | ||
| Biochemical evidence for gamma-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat | Q71167470 | ||
| The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain | Q71483856 | ||
| Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry | Q71489306 | ||
| GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area | Q71610037 | ||
| Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons | Q72269302 | ||
| Cholinergic inhibition of ventral midbrain dopamine neurons | Q73066577 | ||
| Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice | Q73264277 | ||
| Burst firing in midbrain dopaminergic neurons | Q74293267 | ||
| Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data | Q30807024 | ||
| Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons | Q32063805 | ||
| Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia | Q32129579 | ||
| Afferent modulation of dopamine neuron firing patterns | Q33801734 | ||
| Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids | Q34166712 | ||
| Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra | Q34421920 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons | Q34749332 | ||
| Addictive potential of cannabinoids: the underlying neurobiology | Q35035878 | ||
| The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions | Q35045001 | ||
| Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals. | Q35045579 | ||
| Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. | Q38308428 | ||
| Spillover in the spotlight | Q41748061 | ||
| Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient | Q42502076 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Synthesis of phenylglycine derivatives as potent and selective antagonists of group III metabotropic glutamate receptors | Q43558546 | ||
| Muscarine reduces calcium-dependent electrical activity in substantia nigra dopaminergic neurons | Q43814506 | ||
| GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo | Q43908487 | ||
| Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. | Q43972718 | ||
| Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids | Q44051647 | ||
| Firing modes of midbrain dopamine cells in the freely moving rat. | Q44120311 | ||
| Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens | Q44299680 | ||
| Metabotropic glutamate and muscarinic cholinergic receptor-mediated preferential inhibition of N-methyl-D-aspartate component of transmissions in rat ventral tegmental area | Q44345598 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum | Q44385248 | ||
| Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission | Q44536213 | ||
| Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. | Q44723162 | ||
| Dopamine operates as a subsecond modulator of food seeking. | Q44762650 | ||
| CGP 35348: a centrally active blocker of GABAB receptors | Q44810216 | ||
| Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. | Q44885114 | ||
| Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat. | Q47734663 | ||
| GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. | Q47921750 | ||
| Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump | Q47931189 | ||
| Membrane properties of rat locus coeruleus neurones | Q47953427 | ||
| A morphological evidence for monosynaptic projections from the nucleus tegmenti pedunculopontinus pars compacta (TPC) to nigrostriatal projection neurons | Q48111614 | ||
| Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. | Q48175690 | ||
| Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons | Q48203898 | ||
| Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity | Q48399995 | ||
| Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area | Q48469772 | ||
| Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology | Q48488621 | ||
| Glutamate metabotropic receptor agonists depress excitatory and inhibitory transmission on rat mesencephalic principal neurons | Q48535400 | ||
| Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons | Q48550405 | ||
| A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids | Q48794204 | ||
| The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. | Q50933545 | ||
| Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brainin vivo | Q63256029 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoids | Q10483908 |
| P304 | page(s) | 11070-11078 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area | |
| P478 | volume | 24 |
| Q34264449 | A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. |
| Q28728678 | A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation |
| Q33975305 | Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs. |
| Q47445865 | Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids |
| Q37060812 | Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice |
| Q39920030 | Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli |
| Q34676610 | Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? |
| Q37164812 | Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies |
| Q33969858 | CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking |
| Q42136572 | Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization |
| Q34451442 | Cannabinoid modulation of drug reward and the implications of marijuana legalization |
| Q34248777 | Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output |
| Q36342981 | Cannabinoid receptor 1-expressing neurons in the nucleus accumbens |
| Q48523125 | Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. |
| Q36395211 | Cannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals. |
| Q38522769 | Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia |
| Q21090468 | Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far |
| Q46932814 | Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. |
| Q42258332 | Cannabinoids in Parkinson's Disease |
| Q22252549 | Cannabis and psychosis: Have we found the missing links? |
| Q34699888 | Cannabis, the mind and society: the hash realities |
| Q45814311 | Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling. |
| Q50658951 | Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. |
| Q27320220 | Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area |
| Q83227323 | Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion |
| Q38539996 | Cognitive and autonomic determinants of energy homeostasis in obesity |
| Q37821386 | Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse |
| Q36198137 | Dopaminergic neurones: much more than dopamine? |
| Q34575484 | Drug addiction. |
| Q37310301 | Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions |
| Q36542357 | Dual roles of dopamine in food and drug seeking: the drive-reward paradox |
| Q41865699 | Effect of Acetaldehyde Intoxication and Withdrawal on NPY Expression: Focus on Endocannabinoidergic System Involvement |
| Q36201313 | Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats |
| Q35196626 | Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. |
| Q47319226 | Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens |
| Q39400299 | Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling |
| Q39267685 | Endocannabinoid modulation of dopamine neurotransmission |
| Q34967151 | Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? |
| Q30373359 | Endocannabinoid signalling in reward and addiction. |
| Q38250054 | Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues |
| Q28282026 | Endocannabinoid-dependent regulation of feedforward inhibition in cerebellar Purkinje cells |
| Q33583792 | Endocannabinoids and striatal function: implications for addiction-related behaviours |
| Q48306103 | Endocannabinoids and the Non-Homeostatic Control of Appetite |
| Q40794240 | Endocannabinoids and the processing of value-related signals |
| Q27687624 | Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs |
| Q52640715 | Fatty acid-binding proteins 5 and 7 gene deletion increases sucrose consumption and diminishes forced swim immobility time. |
| Q55346929 | Hedonic Eating and the "Delicious Circle": From Lipid-Derived Mediators to Brain Dopamine and Back. |
| Q90245278 | Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users |
| Q24623244 | Hub and switches: endocannabinoid signalling in midbrain dopamine neurons |
| Q36452302 | Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
| Q40251961 | Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway. |
| Q28283718 | Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction |
| Q46755929 | Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo |
| Q48255013 | Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo |
| Q33923685 | Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells |
| Q33560844 | Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain |
| Q35626920 | Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers |
| Q34990029 | Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome |
| Q45763902 | Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area. |
| Q30243992 | Obesity: Current and potential pharmacotherapeutics and targets |
| Q89267150 | Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol |
| Q37128023 | Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons. |
| Q55255522 | Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons. |
| Q36943246 | Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. |
| Q53404854 | Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. |
| Q34605939 | Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. |
| Q33880993 | Phasic dopamine release in appetitive behaviors and drug addiction |
| Q46504765 | Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons. |
| Q30500429 | Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine |
| Q39556033 | Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis |
| Q37495511 | Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self-Administration by Wistar Rats. |
| Q43055373 | Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons |
| Q38019926 | Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors |
| Q33599036 | Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes |
| Q36373102 | Roles for the endocannabinoid system in ethanol-motivated behavior. |
| Q46424750 | Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris). |
| Q48217027 | Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. |
| Q34524803 | Striatal dopamine neurotransmission: regulation of release and uptake |
| Q36358712 | Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate |
| Q37040227 | Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. |
| Q64229781 | The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder |
| Q90049232 | The Neuroscience of Drug Reward and Addiction |
| Q35989527 | The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q36741861 | The endocannabinoid system in brain reward processes |
| Q100423040 | The endocannabinoid system in humans: significant associations between anandamide, brain function during reward feedback and a personality measure of reward dependence |
| Q37291517 | The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. |
| Q30499665 | The small-conductance calcium-activated potassium channel is a key modulator of firing and long-term depression in the dorsal striatum |
| Q26770739 | To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making |
| Q36265810 | Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements |
| Q92972277 | Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood |
Search more.